# 7 Million Insulin Pumps Recalled Over Dangerous Defect, FDA Warns
The FDA issued a recall notice affecting approximately 7 million insulin pumps due to a software defect that could allow unauthorized remote access to the devices. The vulnerability poses serious risks to people with diabetes who depend on these pumps for life-sustaining insulin delivery.
The defect enables attackers to potentially alter insulin dosing remotely, which could result in dangerously high or low blood sugar levels. People using affected pumps face risks ranging from hyperglycemia to severe hypoglycemia, conditions that require immediate medical attention and can become life-threatening if left untreated.
The FDA issued this warning to alert healthcare providers and patients to the vulnerability. The agency recommends that anyone using an affected pump contact their manufacturer immediately to understand their specific device status and available solutions. Manufacturers have begun rolling out software updates to patch the security flaw.
People with diabetes should not stop using their pumps while awaiting updates, as insulin therapy remains essential to their health. Instead, they should take precautions such as keeping their pump's software current, avoiding connecting to unsecured networks, and monitoring blood sugar levels more frequently during the transition period if advised by their healthcare provider.
This recall highlights the growing intersection between medical device security and diabetes management. As insulin pumps become increasingly connected and programmable, manufacturers face pressure to balance functionality with robust cybersecurity protections. The FDA continues to work with pump manufacturers to implement stronger safeguards and faster response protocols for future vulnerabilities.
People with diabetes who use insulin pumps should review their device manufacturer's recall information and follow recommended steps. Speaking with an endocrinologist or diabetes educator about the recall and any concerns about their specific device remains important during this transition period.